Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study

Status Terminated

Clinical Trial Summary

Fetal heart rate [FHR] monitoring is used widely to assess the well-being of the baby in the delivery period. If it is determined that an urgent cesarean delivery is required because of fetal distress, FHR is discontinued once the mother is in the operating room in order to allow for surgical site preparation. From this point, there is no real-time monitoring that permits assessment of the well-being of the infant. The investigators are evaluating the feasibility of intraoperative FHR monitoring using fetal ECG placed on the mother's upper abdominal wall and the standard acoustic device routinely used. The investigators will compare these to the traditional well-being tests: umbilical arterial blood gas and Apgar score.

The first 15 subjects will be recruited from pregnant women who have scheduled induction of labor. The subsequent 40 subjects will be recruited from pregnant women who have scheduled cesarean sections.

Clinical Trial Description

Fetal heart rate (FHR) monitoring has become the most widely used assessment of fetal well-being in the peripartum period and the only routinely used method that provides continuous fetal monitoring. Despite a false positive rate for the detection of intrapartum asphyxia leading to cerebral palsy of over 99% [1-3] FHR monitoring continues to be the mainstay of peripartum fetal surveillance. FHR monitoring is routinely available in the operating room, where it is typically reassessed in cases of urgent cesarean delivery for fetal distress since it may direct immediate anesthetic and peripartum management. However, despite the ubiquitous use of FHR monitoring in labor and the typical use of FHR monitoring on arrival to the OR, FHR monitoring is universally stopped once anesthesia has been performed in order to allow abdominal skin preparation and for surgery to proceed. From the moment of anesthesia induction until fetal delivery, no real-time data is available that allows assessment of fetal well-being. A few isolated studies and case reports in the 1970s-1980s examined intraoperative FHR monitoring using scalp-clip electrodes during Cesarean deliveries [4-7]. None of these studies assessed external FHR monitors or current anesthesia techniques. To the investigators' knowledge no studies since that time have examined FHR monitoring during Cesarean deliveries using external monitoring or spinal anesthesia ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02950896
Study type	Observational
Source	Washington University School of Medicine
Contact
Status	Terminated
Phase
Start date	October 2016
Completion date	October 29, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03244865` - Refinement of the OBMedical LaborView System
Not yet recruiting	`NCT05933928` - The Effect of Simulation-based Electronic Fetal Monitoring Training on Midwifery Students	N/A
Completed	`NCT04779294` - The Oslo Stan vs Lactate Observational Study
Recruiting	`NCT05938790` - Point of Care Ultrasound in Obstetric Triage	N/A
Not yet recruiting	`NCT05510349` - Prevention of Per-partum Fetal Hypoxia: Measure of Placental Elasticity and Viscosity During Labor	N/A
Not yet recruiting	`NCT03268486` - Evaluation of a Novel Signal Acquisition Technique for Intrapartum Cardiotocography	N/A
Recruiting	`NCT06135961` - Intrapartum Non-invasive Electrophysiological Monitoring	N/A
Recruiting	`NCT05847790` - Remote Pregnancy Monitoring to Improve Access	N/A
Completed	`NCT02790554` - Moyo; strap-on Fetal Heart Rate Monitoring in an Urban Setting	N/A
Completed	`NCT05060172` - A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Antepartum Fetal Monitoring	N/A
Recruiting	`NCT03111173` - Can Conventional ECG Technology Capture Fetal Cardiac Activity?	N/A
Recruiting	`NCT05665400` - A Clinical Study for the Development of a Device (Lovelace) for Antepartum Fetal Monitoring	N/A
Completed	`NCT02790814` - Moyo; strap-on Fetal Heart Rate Monitoring in a Rural Setting	N/A
Completed	`NCT05863156` - Evaluation of the Effects of Different Positions Given During Antenatal Electro-Fetal Monitoring	N/A
Completed	`NCT04915131` - A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Performing Antepartum Fetal Monitoring	N/A
Not yet recruiting	`NCT06355453` - Evaluation of the Goldcrest Patch Performance

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.